Interleukin-37 attenuates acute lung injury by inhibiting inflammatory response in a mouse CLP model

Gene Therapy and Molecular Biology

Volumn 15, Issue 1, 2013, Pages 176-184

  Chen, Xiangjun ^a   Huang, Juan ^a   Chen, Min ^a   Huang, Yingde ^a   Li, Nian ^a   Liu, Fang ^a   Pu, Dan ^a   Zhou, Taoyou ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Acute lung injury; Cecal ligation and puncture; Cytokines; IL 37; Sepsis

Indexed keywords

CXCL2 CHEMOKINE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 37; INTERLEUKIN 4; INTERLEUKIN 6; MALONALDEHYDE; MYELOPEROXIDASE; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COUNT; CYTOKINE PRODUCTION; DRUG EFFECT; DRY WEIGHT; ENZYME ACTIVITY; INFLAMMATION; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; SEPSIS; SURVIVAL TIME; TREATMENT RESPONSE;

EID: 84902265000     PISSN: 15299120     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Sriskandan S, Altmann DM (2008) The immunology of sepsis. J Pathol 214,211-223.
2. Nguyen HB, Smith D (2007) Sepsis in the 21st century: recent definitions and therapeutic advances.Am J Emerg Med 25,564-571.
3. Alves-Filho JC, Sônego F, Souto FO, Freitas A, Verri WA Jr, Auxiliadora-Martins M, Basile-Filho A, McKenzie AN, Xu D, Cunha FQ, Liew FY (2010) Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat Med 16,708-712.
4. Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, Al-Abed Y, Wang H, Metz C, Miller EJ, Tracey KJ, Ulloa L (2004) Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10,1216-1221.
5. Cavaillon JM, Adib-Conquy M, Fitting C, Adrie C, Payen D (2003) Cytokine cascade in sepsis. Scand J Infect Dis 35,535-544.
6. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, Bozza MT, Castro-Faria-Neto HC, Bozza PT (2007) Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 11, R49.
7. Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA (2010) IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 11,1014-1022.
8. Bufler P (2011) Interleukin-37 as fundamental inhibitor of innate immunity. Arthritis Res Ther 13,15.
9. Sharma S, Kulk N, Nold MF, Gräf R, Kim SH, Reinhardt D, Dinarello CA, Bufler P (2008) The IL-1 family member 7b translocates to the nucleus and downregulates proinflammatory cytokines.J Immunol 180, 5477-5482.
10. McNamee EN, Masterson JC, Jedlicka P, McManus M, Grenz A, Collins CB, Nold MF, Nold-Petry C, Bufler P, Dinarello CA, Rivera-Nieves J (2011) Interleukin 37 expression protects mice from colitis.Proc Natl Acad Sci U S A 108, 16711-16716.
11. Alves-Filho JC, de Freitas A, Russo M, Cunha FQ (2006) Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis. Crit. Care Med 34,461-470.
12. Zhao D, Ding R, Mao Y, Wang L, Zhang Z, Ma X (2012) Heparin Rescues Sepsis-Associated Acute Lung Injury and Lethality Through the Suppression of Inflammatory Responses. Inflammation 35,1825-1832.
13. Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA (2009) Immunodesign of experimental sepsis by cecal ligation and puncture.Nat Protoc 4,31-36.
14. Netea MG, van der Meer JW, van Deuren M, Kullberg BJ (2003) Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing?. Trends Immunol 24,254-258.
15. Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, Fine J, Krichevsky A, Delude RL, Angus DC; GenIMS Investigators (2007) Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 167, 1655-1663.